Michel Zelaquett/LinkedIn
Apr 23, 2026, 07:33
Michel Zelaquett: Ultra-Minimally Invasive Treatment for Uterine Fibroids
Michel Zelaquett, Founder and Director at Centro de Mioma, shared a post on LinkedIn:
“Ultra-Minimally Invasive Treatment for Uterine Fibroids
No incisions. No scars. Minimal invasion, maximum precision.
Cutting-edge technology in service of uterine preservation and fertility — because every woman deserves access to treatments that respect her body and her future.
Proud to be part of a dedicated team pushing the boundaries of modern gynecology.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 13, 2026, 16:58Slavian Bumbu: A Low AMH Is Not an Infertility Diagnosis
-
Oct 13, 2026, 16:43Keshav Malhotra: No Embryologist or Laboratory Technique Can Guarantee Euploid Embryos
-
Oct 13, 2026, 16:37Tony Gordon: What Is the Most Successful Form of Fertility Treatment?
-
Oct 13, 2026, 16:29IVI RMA Global Introduces IVI Fertility
-
Oct 13, 2026, 16:12Devyanshi Dixit: PCOS May Be One Diagnosis, But Is It One Biological Disease?
-
Oct 13, 2026, 16:00Rajeev Agarwal: Age and Male Fertility, Through the PREPARE Method
-
Oct 13, 2026, 15:505 Years of the Patient Engagement Forum – HFEA
-
Oct 13, 2026, 15:41Cell-Free Fetal DNA Testing for Single-Gene Conditions – RCOG
-
Oct 13, 2026, 15:24Somil Singhal: Method for Enhancing Embryo Implantation Using Embryo Glue and Its Importance